H-1B Filings
13
DOL labor condition applications on file
Kite Pharma Inc. in CA (Professional & Technical Services) is a sponsorship-and-safety profile: 13 H-1B LCAs plus an employer-specific OSHA injury record, with no WARN notices in this corpus.
Kite Pharma Inc. (CA): · 13 H-1B LCAs at a $136,011 disclosed median · OSHA Grade F (DART 1.96)
According to DOL OFLC H-1B disclosures, OSHA ITA injury logs, and state WARN Act notices, Kite Pharma Inc. in CA carries 13 H-1B wage filings on record, a $136,011 median wage (above the $120,000 national median), a weak F OSHA safety grade and no WARN layoff notices on file. H-1B filing volume ranks #2,202 of 36,919 sponsors in this corpus (about the 94th percentile). Every figure is a federal filing, not an estimate; see methodology for coverage limits.
The record at a glance
According to U.S. Department of Labor, OSHA, and state WARN Act filings, Kite Pharma Inc. carries 13 H-1B wage filings on record, a $136,011 median wage (above the $120,000 national median), a weak F OSHA safety grade and no WARN layoff notices on file. In this corpus, H-1B filing volume ranks #2,202 of 36,919 sponsors in this corpus (about the 94th percentile), and disclosed median wage sits at the 63rd percentile of 178,031 credible H-1B wage rows.
Figures above come from DOL H-1B LCAs and this employer's OSHA injury log; no WARN notices are on file here.
DOL LCA release change
H-1B Filings
13
DOL labor condition applications on file
Median H-1B Salary
$136,011
Across 13 disclosed positions
OSHA Safety Grade
Grade F · DART 1.96
vs 0.27 same 2-digit NAICS sector (OSHA ITA 2022–2023, hours-weighted)
Where Kite Pharma Inc.'s H-1B wage sits nationally
Median disclosed wage vs. all US employers with H-1B filings
$136,011 Top 37% higher than 63% of 178,031 US employers
Each bar is a $20K-wide band; taller bars hold more US employers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source DOL Office of Foreign Labor Certification, H-1B Disclosure Data · August 2026
Filing-count-weighted median across this employer's own disclosed H-1B positions (+18.2% year over year), not a company-wide raise, and not adjusted for role mix changes between years.
| Field | Value | Source |
|---|---|---|
| Employer Name | Kite Pharma Inc. | DOL OFLC / OSHA |
| Industry | Professional & Technical Services | NAICS / DOL |
| State | CA | U.S. Federal Records |
| H-1B Filings | 13 | DOL OFLC LCA Disclosure |
| H-1B Median Salary | $136,011 | DOL OFLC LCA Disclosure |
| OSHA Safety Grade | F | OSHA ITA |
| OSHA DART Rate | 1.96 | OSHA ITA Establishment Records |
| Tracks not on file | WARN notices | Empty by design, not estimated |
Kite Pharma Inc.'s values above reflect the most recent DOL Labor Condition Applications, OSHA Injury Tracking Application records on file for this employer in CA (Professional & Technical Services).
| Job Title | Median |
|---|---|
| Director Global Commercial Strategy YESCARTA/TECARTUS | $211,994 |
| Associate Director, R&D Quality | $204,859 |
| Assoc Director, Marketing Sciences | $199,410 |
| Associate Director, Marketing Sciences | $183,668 |
| Manager, IT Project Management | $152,693 |
| Manager, IT Business Analysis | $146,994 |
| Senior Manager, Competitive Intelligence | $136,011 |
| Senior Manager, Marketing Sciences | $132,933 |
| Senior Manager, Biostatistics | $118,664 |
| FP & A Manager | $102,670 |
| FP & A Manager | $102,670 |
| Sr. Research Associate I, Cell Biology | $96,795 |
| Research Scientist, Bioinformatics | $95,014 |
Kite Pharma Inc. operating in CA within the Professional & Technical Services sector: the company has filed 13 H-1B labor condition applications, of which 13 disclose a usable wage figure with a median of $136,011. Records here combine U.S. Department of Labor disclosures and state workforce agency filings.
On workplace safety, Kite Pharma Inc. posted a DART (Days Away, Restricted, Transferred) rate of 1.96 injuries per 100 full-time workers, compared with the hours-weighted average of 0.27 for the same 2-digit NAICS sector in OSHA ITA 2022–2023 filings. Our composite grade of "F" is that employer-to-sector ratio (A ≤0.5× sector · B ≤0.8× · C ≤1.2× · D ≤1.8× · else F), so a job seeker can compare a hospital chain to a warehouse or a bank to a food processor without chasing down OSHA formulas. Across all years on file, OSHA logged 46 reportable injuries at this employer.
For Kite Pharma Inc., the usable public record is dominated by H-1B labor-condition applications (13 on this profile) in Professional & Technical Services; those filings are sponsorship intent, not headcount, and cuts below the WARN threshold may never appear here.
Kite Pharma Inc.'s DART rate (days away/restricted/transferred per 100 FTE) vs the hours-weighted 2-digit NAICS sector average from OSHA ITA 2022–2023 (Professional & Technical Services).
Total reported injuries on file: 46.
Kite Pharma Inc.'s nearest H-1B-filing peers in Professional & Technical Services (home state CA). Each card links to that employer's federal-records profile.
What to check before working with Kite Pharma Inc.
For Kite Pharma Inc., read sponsorship pay (13 H-1B LCAs, median $136,011) next to the OSHA safety grade (F).
Kite Pharma Inc.'s figures are legally filed public records (DOL, OSHA, state WARN), not reviews or vendor estimates; a missing row is not proof the underlying activity never happened.
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.
Learn more: Safety Grades Explained | H-1B Salary Negotiation
Read our methodology - how this data is sourced, computed, and verified.
This profile is rendered directly from DOL H-1B disclosure filings and OSHA Injury Tracking Application records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.